Abstract
Human infections with the food-borne pathogen Campylobacter jejuni are progressively increasing worldwide and constitute a significant socioeconomic burden to mankind. Intestinal campylobacteriosis in humans is characterized by bloody diarrhea, fever, abdominal pain, and severe malaise. Some individuals develop chronic post-infectious sequelae including neurological and autoimmune diseases such as reactive arthritis and Guillain-Barré syndrome. Studies unraveling the molecular mechanisms underlying campylobacteriosis and post-infectious sequelae have been hampered by the scarcity of appropriate experimental in vivo models. Particularly, conventional laboratory mice are protected from C. jejuni infection due to the physiological colonization resistance exerted by the murine gut microbiota composition. Additionally, as compared to humans, mice are up to 10,000 times more resistant to C. jejuni lipooligosaccharide (LOS) constituting a major pathogenicity factor responsible for the immunopathological host responses during campylobacteriosis. In this chapter, we summarize the recent progress that has been made in overcoming these fundamental obstacles in Campylobacter research in mice. Modification of the murine host-specific gut microbiota composition and sensitization of the mice to C. jejuni LOS by deletion of genes encoding interleukin-10 or a single IL-1 receptor-related molecule as well as by dietary zinc depletion have yielded reliable murine infection models resembling key features of human campylobacteriosis. These substantial improvements pave the way for a better understanding of the molecular mechanisms underlying pathogen–host interactions. The ongoing validation and standardization of these novel murine infection models will provide the basis for the development of innovative treatment and prevention strategies to combat human campylobacteriosis and collateral damages of C. jejuni infections.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler HE, DaMassa AJ (1979) Toxicity of endotoxin to chicks. Avian Dis 23(1):174–178
Alter T, Bereswill S, Glünder G, Haag L-M, Hänel I, Heimesaat M, Lugert R, Rautenschlein S, Weber R, Zautner A (2011) Die Campylobacteriose des Menschen. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 54(6):728–734. https://doi.org/10.1007/s00103-011-1289-y
Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, Ueha S, Matsushima K, Ohno H, Olle B, Sakaguchi S, Taniguchi T, Morita H, Hattori M, Honda K (2013) Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 500(7461):232–236. https://doi.org/10.1038/nature12331
Auerbach S (1965) Zinc content of plasma, blood, and erythrocytes in normal subjects and in patients with hodgkin’s disease and various hematologic disorders. J Lab Clin Med 65:628–637
Babakhani FK, Bradley GA, Joens LA (1993) Newborn piglet model for campylobacteriosis. Infect Immun 61(8):3466–3475. https://doi.org/10.1128/IAI.61.8.3466-3475.1993
Backert S, Tegtmeyer N, Cróinín TÓ, Boehm M, Heimesaat MM (2017) Chapter 1 - Human campylobacteriosis. In: Klein G (ed) Campylobacter. Academic Press, pp 1–25. https://doi.org/10.1016/B978-0-12-803623-5.00001-0
Beery JT, Hugdahl MB, Doyle MP (1988) Colonization of gastrointestinal tracts of chicks by Campylobacter jejuni. Appl Environ Microbiol 54(10):2365–2370. https://doi.org/10.1128/AEM.54.10.2365-2370.1988
Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kuhl AA, Dasti JI, Zautner AE, Munoz M, Loddenkemper C, Gross U, Gobel UB, Heimesaat MM (2011) Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS ONE 6(6):e20953. https://doi.org/10.1371/journal.pone.0020953
Boehm M, Simson D, Escher U, Schmidt AM, Bereswill S, Tegtmeyer N, Backert S, Heimesaat MM. (2018) Function of Serine Protease HtrA in the Lifecycle of the Foodborne Pathogen Campylobacter jejuni. Eur J Microbiol Immunol (Bp). 8(3):70–77. https://doi.org/10.1556/1886.2018.00011
Bolton DJ (2015) Campylobacter virulence and survival factors. Food Microbiol 48:99–108. https://doi.org/10.1016/j.fm.2014.11.017
Brown J, Wang H, Hajishengallis GN, Martin M (2011) TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 90(4):417–427. https://doi.org/10.1177/0022034510381264
Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nature Rev Immunol 13(11):790–801. https://doi.org/10.1038/nri3535
Cario E, Podolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68(12):7010. https://doi.org/10.1128/IAI.68.12.7010-7017.2000
Chang C, Miller JF (2006) Campylobacter jejuni colonization of mice with limited enteric flora. Infect Immun 74(9):5261–5271. https://doi.org/10.1128/IAI.01094-05
Cochet F, Peri F (2017) The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling. Int J Molecul Sci 18(11). https://doi.org/10.3390/ijms18112318
Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP (2008) Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319(5865):962–965. https://doi.org/10.1126/science.1152449
Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221–1227. https://doi.org/10.1136/gut.28.10.1221
Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U (2010) Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol 300(4):205–211. https://doi.org/10.1016/j.ijmm.2009.07.002
de Zoete MR, Keestra AM, Roszczenko P, van Putten JP (2010) Activation of human and chicken toll-like receptors by Campylobacter spp. Infect Immun 78(3):1229–1238. https://doi.org/10.1128/iai.00897-09
Dicksved J, Ellstrom P, Engstrand L, Rautelin H (2014) Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota. mBio 5(5):e01212–01214. https://doi.org/10.1128/mBio.01212-14
Diker K, Hascelik G, Diker S (1992) Colonization of infant mice with flagellar variants of Campylobacter jejuni. Acta microbiologica Hungarica 39(2):133–136
Dorrell N, Wren BW (2007) The second century of Campylobacter research: recent advances, new opportunities and old problems. Curr Opin Infect Dis 20(5):514–518. https://doi.org/10.1097/QCO.0b013e3282a56b15
Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ (2019) Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol Molecul Biol Rev MMBR 83(3). https://doi.org/10.1128/mmbr.00007-19
EFSA (2019) European Food Safety Authority. european centre for disease, prevention control,the european union one health 2018 Zoonoses Report. EFSA J 17(12):e05926. https://doi.org/10.2903/j.efsa.2019.5926
Ellström P, Hansson I, Nilsson A, Rautelin H, Engvall EO (2016) Lipooligosaccharide locus classes and putative virulence genes among chicken and human Campylobacter jejuni isolates. BMC Microbiol 16(1):116. https://doi.org/10.1186/s12866-016-0740-5
Emoto M, Emoto Y, Brinkmann V, Miyamoto M, Yoshizawa I, Staber M, van Rooijen N, Hamann A, Kaufmann SH (2003) Increased resistance of LFA-1-deficient mice to lipopolysaccharide-induced shock/liver injury in the presence of TNF-alpha and IL-12 is mediated by IL-10: a novel role for LFA-1 in the regulation of the proinflammatory and anti-inflammatory cytokine balance. J Immunol 171(2):584–593. https://doi.org/10.4049/jimmunol.171.2.584
Erridge C, Duncan SH, Bereswill S, Heimesaat MM (2010) The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS ONE 5(2):e9125. https://doi.org/10.1371/journal.pone.0009125
Ferrero RL, Lee A (1988) Motility of Campylobacter jejuni in a viscous environment: comparison with conventional rod-shaped bacteria. J Gen Microbiol 134(1):53–59. https://doi.org/10.1099/00221287-134-1-53
Fiebiger U, Bereswill S, Heimesaat MM (2016) Dissecting the interplay between intestinal microbiota and host immunity in health and disease: lessons learned from germfree and gnotobiotic animal models. Eur J Microbiol Immunol (Bp) 6(4):253–271. https://doi.org/10.1556/1886.2016.00036
Fox JG, Ackerman JI, Taylor N, Claps M, Murphy JC (1987) Campylobacter jejuni infection in the ferret: an animal model of human campylobacteriosis. Am J Veterinary Res 48(1):85–90
Fox JG, Rogers AB, Whary MT, Ge Z, Taylor NS, Xu S, Horwitz BH, Erdman SE (2004) Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun 72(2):1116–1125. https://doi.org/10.1128/iai.72.2.1116-1125.2004
Gammoh NZ, Rink L (2017) Zinc in infection and inflammation. Nutrients 9(6):624. https://doi.org/10.3390/nu9060624
Genger C, Kløve S, Mousavi S, Bereswill S, Heimesaat MM (2020) The conundrum of colonization resistance against Campylobacter reloaded: the gut microbota composition in conventional mice does not prevent from Campylobacter coli infection. Eur J Microbiol Immunol (Bp). https://doi.org/10.1556/1886.2020.00004
Ghosh TS, Gupta SS, Bhattacharya T, Yadav D, Barik A, Chowdhury A, Das B, Mande SS, Nair GB (2014) Gut microbiomes of Indian children of varying nutritional status. PLoS ONE 9(4):e95547. https://doi.org/10.1371/journal.pone.0095547
Giallourou N, Medlock GL, Bolick DT, Medeiros PH, Ledwaba SE, Kolling GL, Tung K, Guerry P, Swann JR, Guerrant RL (2018) A novel mouse model of Campylobacter jejuni enteropathy and diarrhea. PLoS Pathog 14(3):e1007083. https://doi.org/10.1371/journal.ppat.1007083
Gilbert M, Brisson JR, Karwaski MF, Michniewicz J, Cunningham AM, Wu Y, Young NM, Wakarchuk WW (2000) Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-mhz (1)h and (13)c NMR analysis. J Biol Chem 275 (6):3896–3906. https://doi.org/10.1074/jbc.275.6.3896
Gilbert M, Godschalk PC, Karwaski MF, Ang CW, van Belkum A, Li J, Wakarchuk WW, Endtz HP (2004) Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barre syndrome, by horizontal exchange. Infect Immun 72(2):1162–1165. https://doi.org/10.1128/iai.72.2.1162-1165.2004
Gilbert M, Karwaski MF, Bernatchez S, Young NM, Taboada E, Michniewicz J, Cunningham AM, Wakarchuk WW (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 277(1):327–337. https://doi.org/10.1074/jbc.M108452200
Godschalk PC, Kuijf ML, Li J, St Michael F, Ang CW, Jacobs BC, Karwaski MF, Brochu D, Moterassed A, Endtz HP, van Belkum A, Gilbert M (2007) Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun 75(3):1245–1254. https://doi.org/10.1128/iai.00872-06
Golec M (2007) Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann Agric Environ Med 14(1):1–4
Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H (2009) Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 137(2):495–501. https://doi.org/10.1053/j.gastro.2009.04.001
Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361(9356):512–519. https://doi.org/10.1016/s0140-6736(03)12489-0
Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, Moran AP (2002) Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 70(2):787–793. https://doi.org/10.1128/iai.70.2.787-793.2002
Haag LM, Fischer A, Otto B, Grundmann U, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM (2012a) Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp) 2(1):2–11. https://doi.org/10.1556/EuJMI.2.2012.1.2
Haag LM, Fischer A, Otto B, Plickert R, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM (2012b) Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. PLoS ONE 7(7):e40761. https://doi.org/10.1371/journal.pone.0040761
Haag LM, Fischer A, Otto B, Plickert R, Kuhl AA, Gobel UB, Bereswill S, Heimesaat MM (2012c) Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS ONE 7(5):e35988. https://doi.org/10.1371/journal.pone.0035988
Haase H, Rink L (2009) Functional significance of zinc-related signaling pathways in immune cells. Ann Rev Nutri 29:133–152. https://doi.org/10.1146/annurev-nutr-080508-141119
Habib I, Louwen R, Uyttendaele M, Houf K, Vandenberg O, Nieuwenhuis EE, Miller WG, van Belkum A, De Zutter L (2009) Correlation between genotypic diversity, lipooligosaccharide gene locus class variation, and caco-2 cell invasion potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotyping. Appl Environ Microbiol 75(13):4277–4288. https://doi.org/10.1128/aem.02269-08
Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI (2002) Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3(4):354–359. https://doi.org/10.1038/ni777
Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE (2018) Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign. Epidemiol Infect 146(13):1740–1745. https://doi.org/10.1017/S0950268818001802
He Z, Gharaibeh RZ, Newsome RC, Pope JL, Dougherty MW, Tomkovich S, Pons B, Mirey G, Vignard J, Hendrixson DR, Jobin C (2019) Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut 68(2):289–300. https://doi.org/10.1136/gutjnl-2018-317200
Heimesaat MM, Alutis M, Grundmann U, Fischer A, Tegtmeyer N, Bohm M, Kuhl AA, Gobel UB, Backert S, Bereswill S (2014a) The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Front Cell Infect Microbiol 4:77. https://doi.org/10.3389/fcimb.2014.00077
Heimesaat MM, Alutis ME, Grundmann U, Fischer A, Gobel UB, Bereswill S (2016) The Role of IL-23, IL-22, and IL-18 in Campylobacter Jejuni Infection of Conventional Infant Mice. Eur J Microbiol Immunol (Bp) 6(2):124–136. https://doi.org/10.1556/1886.2016.00008
Heimesaat MM, Bereswill S (2015) Murine infection models for the investigation of Campylobacter jejuni–host interactions and pathogenicity. Berl Munch Tierarztl Wochenschr 128(3–4):98–103
Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Gobel UB, Liesenfeld O (2006) Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 177(12):8785–8795. https://doi.org/10.4049/jimmunol.177.12.8785
Heimesaat MM, Fischer A, Alutis M, Grundmann U, Boehm M, Tegtmeyer N, Gobel UB, Kuhl AA, Bereswill S, Backert S (2014b) The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice. Gut Pathog 6:16. https://doi.org/10.1186/1757-4749-6-16
Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Gobel UB, Bereswill S (2007a) Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56(7):941–948. https://doi.org/10.1136/gut.2006.104497
Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, Jahn HK, Freudenberg M, Loddenkemper C, Batra A, Lehr HA, Liesenfeld O, Blaut M, Gobel UB, Schumann RR, Bereswill S (2007b) Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2(7):e662. https://doi.org/10.1371/journal.pone.0000662
Heimesaat MM, Grundmann U, Alutis ME, Fischer A, Bereswill S (2017) Absence of Nucleotide-Oligomerization-Domain-2 Is associated with less distinct disease in Campylobacter jejuni infected secondary abiotic IL-10 deficient mice. Front Cell Infect Microbiol 7:322. https://doi.org/10.3389/fcimb.2017.00322
Heimesaat MM, Lugert R, Fischer A, Alutis M, Kuhl AA, Zautner AE, Tareen AM, Gobel UB, Bereswill S (2014c) Impact of Campylobacter jejuni cj0268c knockout mutation on intestinal colonization, translocation, and induction of immunopathology in gnotobiotic IL-10 deficient mice. PLoS ONE 9(2):e90148. https://doi.org/10.1371/journal.pone.0090148
Heimesaat MM, Mrazek K, Bereswill S (2019a) Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in Campylobacter jejuni Infected Mice Harboring a Human Gut Microbiota. Front Immunol 10:2272. https://doi.org/10.3389/fimmu.2019.02272
Heimesaat MM, Mrazek K, Bereswill S (2019b) Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice. Sci Rep 9(1):19797. https://doi.org/10.1038/s41598-019-56442-7
Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C, Steinhoff U, Tchaptchet S, Thiel E, Freudenberg MA, Gobel UB, Uharek L (2010) MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59(8):1079–1087. https://doi.org/10.1136/gut.2009.197434
Hermans D, Pasmans F, Heyndrickx M, Van Immerseel F, Martel A, Van Deun K, Haesebrouck F (2012) A tolerogenic mucosal immune response leads to persistent Campylobacter jejuni colonization in the chicken gut. Crit Rev Microbiol 38(1):17–29. https://doi.org/10.3109/1040841x.2011.615298
HMPC (2012) Human Microbiome Project Consortium 2012. Struct Function Divers Healthy Human Microbiome Nature 486:207–214. https://doi.org/10.1038/nature11234
Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature Rev Immunol 10(3):159–169. https://doi.org/10.1038/nri2710
Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168(9):4531–4537. https://doi.org/10.4049/jimmunol.168.9.4531
Houliston RS, Vinogradov E, Dzieciatkowska M, Li J, St Michael F, Karwaski M-F, Brochu D, Jarrell HC, Parker CT, Yuki N, Mandrell RE, Gilbert M (2011) Lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosides. J Biol Chem 286(14):12361–12370. https://doi.org/10.1074/jbc.M110.181750
Iizumi T, Taniguchi T, Yamazaki W, Vilmen G, Alekseyenko AV, Gao Z, Perez Perez GI, Blaser MJ (2016) Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog 8:60. https://doi.org/10.1186/s13099-016-0143-z
Imaeda H, Yamamoto H, Takaki A, Fujimiya M (2002) In vivo response of neutrophils and epithelial cells to lipopolysaccharide injected into the monkey ileum. Histochemistry Cell Biol 118(5):381–388. https://doi.org/10.1007/s00418-002-0458-3
Iwami K-i, Matsuguchi T, Masuda A, Kikuchi T, Musikacharoen T, Yoshikai Y (2000) Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J Immunol 165(12):6682–6686. https://doi.org/10.4049/jimmunol.165.12.6682
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D (2015) Role of the normal gut microbiota. World J Gastroenterol 21(29):8787–8803. https://doi.org/10.3748/wjg.v21.i29.8787
Jesudason MV, Hentges DJ, Pongpech P (1989) Colonization of mice by Campylobacter jejuni. Infect Immun 57(8):2279–2282. https://doi.org/10.1128/IAI.57.8.2279-2282.1989
Jungi TW, Farhat K, Burgener IA, Werling D (2011) Toll-like receptors in domestic animals. Cell Tissue Res 343(1):107–120. https://doi.org/10.1007/s00441-010-1047-8
Kampmann C, Dicksved J, Engstrand L, Rautelin H (2016) Composition of human faecal microbiota in resistance to Campylobacter infection. Clinical Microbiol Infect: Official Publication Europ Soci Clinical Microbiol Infect Dis 22(1):61.e61–61.e68. https://doi.org/10.1016/j.cmi.2015.09.004
Kannaki TR, Reddy MR, Shanmugam M, Verma PC, Sharma RP (2010) Chicken toll-like receptors and their role in immunity. World’s Poultry Sci J 66(4):727–738. https://doi.org/10.1017/S0043933910000693
Karlyshev AV, Ketley JM, Wren BW (2005) The Campylobacter jejuni glycome. FEMS Microbiol Rev 29(2):377–390. https://doi.org/10.1016/j.femsre.2005.01.003
Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M (2000) Mouse toll-like receptor 4· MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 275(4):2251–2254. https://doi.org/10.1074/jbc.275.4.2251
Kazmi SU, Roberson BS, Stern NJ (1984) Animal-passed, virulence-enhanced Campylobacter jejuni causes enteritis in neonatal mice. Current Microbiol 11(3):159–164
Keestra AM, de Zoete MR, Bouwman LI, van Putten JP (2010) Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J Immunol 185(1):460–467. https://doi.org/10.4049/jimmunol.0901921
Ketloy C, Engering A, Srichairatanakul U, Limsalakpetch A, Yongvanitchit K, Pichyangkul S, Ruxrungtham K (2008) Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. Vet Immunol Immunopathol 125(1–2):18-30. https://doi.org/10.1016/j.vetimm.2008.05.001
Kim S, Covington A, Pamer EG (2017) The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. Immunol Rev 279(1):90–105. https://doi.org/10.1111/imr.12563
Kist M, Bereswill S (2001) Campylobacter jejuni. Contribut Microbiol 8:150–165. https://doi.org/10.1159/000060405
Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC (2010) TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J Immunol 185(1):748–755. https://doi.org/10.4049/jimmunol.0903014
Larson CL, Shah DH, Dhillon AS, Call DR, Ahn S, Haldorson GJ, Davitt C, Konkel ME (2008) Campylobacter jejuni invade chicken LMH cells inefficiently and stimulate differential expression of the chicken CXCLi1 and CXCLi2 cytokines. Microbiology 154(Pt 12):3835–3847. https://doi.org/10.1099/mic.0.2008/021279-0
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc National Acad Sci United States Amer 102(31):11070–11075. https://doi.org/10.1073/pnas.0504978102
Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI (2008) Evolution of mammals and their gut microbes. Science 320(5883):1647–1651. https://doi.org/10.1126/science.1155725
Lin J, Sahin O, Michel LO, Zhang Q (2003) Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 71(8):4250–4259. https://doi.org/10.1128/iai.71.8.4250-4259.2003
Lippert E, Karrasch T, Sun X, Allard B, Herfarth HH, Threadgill D, Jobin C (2009) Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS ONE 4(10):e7413. https://doi.org/10.1371/journal.pone.0007413
Lobo de Sá FD, Butkevych E, Nattramilarasu PK, Fromm A, Mousavi S, Moos V, Golz JC, Stingl K, Kittler S, Seinige D (2019) Curcumin mitigates immune-induced epithelial barrier dysfunction by Campylobacter jejuni. Int J Molecul Sci 20(19):4830. https://doi.org/10.3390/ijms20194830
Lorne E, Zhao X, Zmijewski JW, Liu G, Park YJ, Tsuruta Y, Abraham E (2009) Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol 41(2):237–245. https://doi.org/10.1165/rcmb.2008-0290OC
Lotz M, Gütle D, Walther S, Ménard S, Bogdan C, Hornef MW (2006) Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Experim Med 203(4):973–984. https://doi.org/10.1084/jem.20050625
Louwen R, Heikema A, van Belkum A, Ott A, Gilbert M, Ang W, Endtz HP, Bergman MP, Nieuwenhuis EE (2008) The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect Immun 76(10):4431–4438. https://doi.org/10.1128/iai.00321-08
Louwen R, Nieuwenhuis EE, van Marrewijk L, Horst-Kreft D, de Ruiter L, Heikema AP, van Wamel WJ, Wagenaar JA, Endtz HP, Samsom J, van Baarlen P, Akhmanova A, van Belkum A (2012) Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures. Infect Immun 80(9):3307–3318. https://doi.org/10.1128/iai.06270-11
Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q (2009) Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 4(2):189–200. https://doi.org/10.2217/17460913.4.2.189
Luethy PM, Huynh S, Ribardo DA, Winter SE, Parker CT, Hendrixson DR (2017) Microbiota-derived short-chain fatty acids modulate expression of Campylobacter jejuni determinants required for commensalism and Virulence. MBio 8(3):e00407–00417. https://doi.org/10.1128/mBio.00407-17
Lundberg R (2019) Humanizing the gut microbiota of mice: Opportunities and challenges. Lab Anim 53(3):244–251. https://doi.org/10.1177/0023677218787554
Malik-Kale P, Parker CT, Konkel ME (2008) Culture of Campylobacter jejuni with sodium deoxycholate induces virulence gene expression. J Bacteriol 190(7):2286–2297. https://doi.org/10.1128/JB.01736-07
Mansfield LS, Bell JA, Wilson DL, Murphy AJ, Elsheikha HM, Rathinam VA, Fierro BR, Linz JE, Young VB (2007) C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. Infect Immun 75(3):1099–1115. https://doi.org/10.1128/IAI.00833-06
Mansfield LS, Patterson JS, Fierro BR, Murphy AJ, Rathinam VA, Kopper JJ, Barbu NI, Onifade TJ, Bell JA (2008) Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype. Microb Pathog 45(4):241–257. https://doi.org/10.1016/j.micpath.2008.05.010
Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339. https://doi.org/10.1136/gutjnl-2015-309990
Masanta WO, Heimesaat MM, Bereswill S, Tareen AM, Lugert R, Gross U, Zautner AE (2013) Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol 2013:526860. https://doi.org/10.1155/2013/526860
Mathur H, Rea MC, Cotter PD, Hill C, Ross RP (2015) The sactibiotic subclass of bacteriocins: an update. Current Protein Peptide Sci 16(6):549–558. https://doi.org/10.2174/1389203716666150515124831
Mayneris-Perxachs J, Lima AA, Guerrant RL, Leite AM, Moura AF, Lima NL, Soares AM, Havt A, Moore SR, Pinkerton R, Swann JR (2016) Urinary N-methylnicotinamide and beta-aminoisobutyric acid predict catch-up growth in undernourished Brazilian children. Sci Rep 6:19780. https://doi.org/10.1038/srep19780
Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449(7164):819–826. https://doi.org/10.1038/nature06246
Medzhitov R, Janeway C Jr (2000) Innate immune recognition: mechanisms and pathways. Immunol Rev 173:89. https://doi.org/10.1034/j.1600-065x.2000.917309.x
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22 (2):240–273, Table of Contents. https://doi.org/10.1128/cmr.00046-08
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765. https://doi.org/10.1146/annurev.immunol.19.1.683
Mortensen NP, Kuijf ML, Ang CW, Schiellerup P, Krogfelt KA, Jacobs BC, van Belkum A, Endtz HP, Bergman MP (2009) Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis. Microbes Infect 11(12):988–994. https://doi.org/10.1016/j.micinf.2009.07.004
Mousavi S, Bereswill S, Heimesaat MM (2020a) Novel Clinical Campylobacter jejuni Infection models based on sensitization of mice to Lipooligosaccharide, a major bacterial factor triggering innate immune responses in human campylobacteriosis. Microorganisms 8(4). https://doi.org/10.3390/microorganisms8040482
Mousavi S, Escher U, Thunhorst E, Kittler S, Kehrenberg C, Bereswill S, Heimesaat MM (2020b) Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice. Sci Rep 10(1):2921. https://doi.org/10.1038/s41598-020-59890-8
Mousavi S, Lobo de Sá FD, Schulzke J-D, Bücker R, Bereswill S, Heimesaat MM (2019) Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model. Front Immunol 10:2094–2094. https://doi.org/10.3389/fimmu.2019.02094
Mousavi S, Schmidt A-M, Escher U, Kittler S, Kehrenberg C, Thunhorst E, Bereswill S, Heimesaat MM (2020c) Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model. Gut Pathog 12:2–2. https://doi.org/10.1186/s13099-019-0343-4
Muller J, Meyer B, Hanel I, Hotzel H (2007) Comparison of lipooligosaccharide biosynthesis genes of Campylobacter jejuni strains with varying abilities to colonize the chicken gut and to invade Caco-2 cells. J Med Microbiol 56(Pt 12):1589–1594. https://doi.org/10.1099/jmm.0.47305-0
Muzio M, Bosisio D, Polentarutti N, D’Amico G, Stoppacciaro A, Mancinelli R, van’t Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164(11):5998–6004. https://doi.org/10.4049/jimmunol.164.11.5998
Naito M, Frirdich E, Fields JA, Pryjma M, Li J, Cameron A, Gilbert M, Thompson SA, Gaynor EC (2010) Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis. J Bacteriol 192(8):2182–2192. https://doi.org/10.1128/jb.01222-09
Newell DG (1986) Monoclonal antibodies directed against the flagella of Campylobacter jejuni: production, characterization and lack of effect on the colonization of infant mice. J Hyg (Lond) 96(2):131–141. https://doi.org/10.1017/s0022172400065906
Newell DG, McBride H, Dolby JM (1985) Investigations on the role of flagella in the colonization of infant mice with Campylobacter jejuni and attachment of Campylobacter jejuni to human epithelial cell lines. J Hyg (Lond) 95(2):217–227. https://doi.org/10.1017/s0022172400062653
Newell DG, Pearson A (1984) The invasion of epithelial cell lines and the intestinal epithelium of infant mice by Campylobacter jejuni/coli. J Diarrhoeal Dis Res 2(1):19–26
Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A (2018) Gut microbiota in the pathogenesis of inflammatory bowel disease. Clinical J Gastroenterol 11(1):1–10. https://doi.org/10.1007/s12328-017-0813-5
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164(7):3476–3479. https://doi.org/10.4049/jimmunol.164.7.3476
O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688–693. https://doi.org/10.1038/sj.embor.7400731
O’Loughlin JL, Samuelson DR, Braundmeier-Fleming AG, White BA, Haldorson GJ, Stone JB, Lessmann JJ, Eucker TP, Konkel ME (2015) The intestinal microbiota influences Campylobacter jejuni colonization and extraintestinal dissemination in mice. Appl Environ Microbiol 81(14):4642–4650. https://doi.org/10.1128/AEM.00281-15
O’Neill LA, Fitzgerald KA, Bowie AG (2003) The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 24(6):286–290. https://doi.org/10.1016/s1471-4906(03)00115-7
Cróinín OT, Backert S (2012) Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? Front Cell Infect Microbiol 2:25. https://doi.org/10.3389/fcimb.2012.00025
Oh E, Jeon B (2015) Contribution of surface polysaccharides to the resistance of Campylobacter jejuni to antimicrobial phenolic compounds. J Antibiot 68(9):591. https://doi.org/10.1038/ja.2015.26
Ohtani M, Hoshii T, Fujii H, Koyasu S, Hirao A, Matsuda S (2012) Cutting edge: mTORC1 in intestinal CD11c + CD11b + dendritic cells regulates intestinal homeostasis by promoting IL-10 production. J Immunol 188(10):4736–4740. https://doi.org/10.4049/jimmunol.1200069
Oldfield NJ, Moran AP, Millar LA, Prendergast MM, Ketley JM (2002) Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent. J Bacteriol 184(8):2100–2107. https://doi.org/10.1128/jb.184.8.2100-2107.2002
Pachathundikandi SK, Lind J, Tegtmeyer N, El-Omar EM, Backert S (2015) Interplay of the Gastric Pathogen Helicobacter pylori with Toll-Like Receptors. Biomed Res Int. 2015:192420. https://doi.org/10.1155/2015/192420
Pachathundikandi SK, Tegtmeyer N, Arnold IC, Lind J, Neddermann M, Falkeis-Veits C, Chattopadhyay S, Brönstrup M, Tegge W, Hong M, Sticht H, Vieth M, Müller A, Backert S (2019) T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat Commun. 10(1):5717. https://doi.org/10.1038/s41467-019-13506-6
Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5(7):e177. https://doi.org/10.1371/journal.pbio.0050177
Peng SL (2005) Signaling in B cells via Toll-like receptors. Current Opin Immunol 17(3):230–236. https://doi.org/10.1016/j.coi.2005.03.003
Perera VN, Nachamkin I, Ung H, Patterson JH, McConville MJ, Coloe PJ, Fry BN (2007) Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies. FEMS Immunol Med Microbiol 50(1):27–36. https://doi.org/10.1111/j.1574-695X.2007.00225.x
Perlman RL (2016) Mouse models of human disease: An evolutionary perspective. Evol Med Public Health 2016(1):170–176. https://doi.org/10.1093/emph/eow014
Poltorak A, He X, Smirnova I, Liu M-Y, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene. Science 282(5396):2085–2088. https://doi.org/10.1126/science.282.5396.2085
Pomare E, Branch W, Cummings J (1985) Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J Clinical Invest 75(5):1448–1454. https://doi.org/10.1172/JCI111847
Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, Ojetti V, Scarpellini E, Gasbarrini A (2013) The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci 17(3):323–333
Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D (1999) Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189(4):615–625. https://doi.org/10.1084/jem.189.4.615
Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118(2):229–241. https://doi.org/10.1016/j.cell.2004.07.002
Rathinam VAK, Appledorn DM, Hoag KA, Amalfitano A, Mansfield LS (2009) Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes. Infect Immun 77(6):2499–2507. https://doi.org/10.1128/IAI.01562-08
Repaske DR, Adler J (1981) Change in intracellular pH of Escherichia coli mediates the chemotactic response to certain attractants and repellents. J Bacteriol 145(3):1196–1208. https://doi.org/10.1128/JB.145.3.1196-1208.1981
Riddle MS, Guerry P (2016) Status of vaccine research and development for Campylobacter jejuni. Vaccine 34(26):2903–2906. https://doi.org/10.1016/j.vaccine.2016.02.080
Ridley AM, Toszeghy MJ, Cawthraw SA, Wassenaar TM, Newell DG (2008) Genetic instability is associated with changes in the colonization potential of Campylobacter jejuni in the avian intestine. J Appl Microbiol 105(1):95–104. https://doi.org/10.1111/j.1365-2672.2008.03759.x
Rink L, Haase H (2007) Zinc homeostasis and immunity. Trends in Immunol 28(1):1–4. https://doi.org/10.1016/j.it.2006.11.005
Robertson SA, Care AS, Skinner RJ (2007) Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod 76(5):738–748. https://doi.org/10.1095/biolreprod.106.056143
Robertson SA, Skinner RJ, Care AS (2006) Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 177(7):4888–4896. https://doi.org/10.4049/jimmunol.177.7.4888
Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, Gill N, Blanchet MR, Mohn WW, McNagny KM, Finlay BB (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 13(5):440–447. https://doi.org/10.1038/embor.2012.32
Sarabi Asiabar A, Asadzadeh Aghdaei H, Zamani S, Bokaie S, Zali MR, Feizabadi MM (2019) Molecular detection of Campylobacter jejuni in patients with Crohn’s disease in Iran. Med J Islam Repub Iran 33:76–76. https://doi.org/10.34171/mjiri.33.76
Satsangi J, Wolstencroft RA, Cason J, Ainley CC, Dumonde DC, Thompson RP (1987) Interleukin 1 in Crohn’s disease. Clin Exp Immunol 67(3):594–605
Schmidt A-M, Escher U, Mousavi S, Tegtmeyer N, Boehm M, Backert S, Bereswill S, Heimesaat MM (2019a) Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model. Gut Pathog 11:24–24. https://doi.org/10.1186/s13099-019-0306-9. https://doi.org/10.1186/s13099-019-0306-9
Schmidt AM, Escher U, Mousavi S, Boehm M, Backert S, Bereswill S, Heimesaat MM (2019b) Protease activity of Campylobacter jejuni HtrA modulates distinct intestinal and systemic immune responses in infected secondary abiotic IL-10 deficient mice. Front Cell Infect Microbiol 9:1–12. https://doi.org/10.3389/fcimb.2019.00079
Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904. https://doi.org/10.1152/physrev.00045.2009
Sham HP, Yu EYS, Gulen MF, Bhinder G, Stahl M, Chan JM, Brewster L, Morampudi V, Gibson DL, Hughes MR (2013) SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathogens 9(8). https://doi.org/10.1371/journal.ppat.1003539
Snyder JP, Amiel E (2018) Regulation of dendritic cell immune function and metabolism by cellular nutrient sensor mammalian target of rapamycin (mTOR). Front Immunol 9:3145. https://doi.org/10.3389/fimmu.2018.03145
Snyder SL, Walker RI (1976) Inhibition of lethality in endotoxin-challenged mice treated with zinc chloride. Infect Immun 13(3):998. https://doi.org/10.1128/IAI.13.3.998-1000.1976
Stahl M, Frirdich E, Vermeulen J, Badayeva Y, Li X, Vallance BA, Gaynor EC (2016) The Helical Shape of Campylobacter jejuni Promotes In Vivo pathogenesis by aiding transit through intestinal mucus and colonization of crypts. Infect Immun 84(12):3399–3407. https://doi.org/10.1128/iai.00751-16
Stahl M, Ries J, Vermeulen J, Yang H, Sham HP, Crowley SM, Badayeva Y, Turvey SE, Gaynor EC, Li X, Vallance BA (2014) A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection. PLoS Pathog 10(7):e1004264. https://doi.org/10.1371/journal.ppat.1004264
Stahl M, Vallance BA (2015) Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection. Gut Microbes 6(2):143–148. https://doi.org/10.1080/19490976.2015.1016691
Stephenson HN, John CM, Naz N, Gundogdu O, Dorrell N, Wren BW, Jarvis GA, Bajaj-Elliott M (2013) Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation. J Biol Chem 288(27):19661–19672. https://doi.org/10.1074/jbc.M113.468298
Sun M, Wu W, Liu Z, Cong Y (2017) Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol 52(1):1–8. https://doi.org/10.1007/s00535-016-1242-9
Sun X, Liu B, Sartor RB, Jobin C (2013) Phosphatidylinositol 3-kinase-gamma signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice. J Immunol 190(1):357–365. https://doi.org/10.4049/jimmunol.1201825
Sun X, Threadgill D, Jobin C (2012) Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology 142(1):86–95.e85. https://doi.org/10.1053/j.gastro.2011.09.042
Sun X, Winglee K, Gharaibeh RZ, Gauthier J, He Z, Tripathi P, Avram D, Bruner S, Fodor A, Jobin C (2018) Microbiota-derived metabolic factors reduce campylobacteriosis in mice. Gastroenterology 154(6):1751–1763.e1752. https://doi.org/10.1053/j.gastro.2018.01.042
Szymanski CM, King M, Haardt M, Armstrong GD (1995) Campylobacter jejuni motility and invasion of Caco-2 cells. Infect Immun 63(11):4295–4300. https://doi.org/10.1128/IAI.63.11.4295-4300.1995
Thambiayya K, Wasserloos K, Kagan VE, Stoyanovsky D, Pitt BR (2012) A critical role for increased labile zinc in reducing sensitivity of cultured sheep pulmonary artery endothelial cells to LPS-induced apoptosis. Am J Physiol Lung Cell Mol Physiol 302(12):L1287–1295. https://doi.org/10.1152/ajplung.00385.2011
Ulevitch RJ (1999) Endotoxin opens the toll gates to innate immunity. Nature Med 5(2):144–145. https://doi.org/10.1038/5504
Vaara M (1992) Agents that increase the permeability of the outer membrane. Microbiol Rev 56(3):395–411
Van Deun K, Pasmans F, Ducatelle R, Flahou B, Vissenberg K, Martel A, Van den Broeck W, Van Immerseel F, Haesebrouck F (2008) Colonization strategy of Campylobacter jejuni results in persistent infection of the chicken gut. Vet Microbiol 130(3–4):285-297. https://doi.org/10.1016/j.vetmic.2007.11.027
van Dijk A, Herrebout M, Tersteeg-Zijderveld MH, Tjeerdsma-van Bokhoven JL, Bleumink-Pluym N, Jansman AJ, Veldhuizen EJ, Haagsman HP (2012) Campylobacter jejuni is highly susceptible to killing by chicken host defense peptide cathelicidin-2 and suppresses intestinal cathelicidin-2 expression in young broilers. Vet Microbiol 160(3–4):347–354. https://doi.org/10.1016/j.vetmic.2012.05.034
van Mourik A, Steeghs L, van Laar J, Meiring HD, Hamstra HJ, van Putten JP, Wosten MM (2010) Altered linkage of hydroxyacyl chains in lipid A of Campylobacter jejuni reduces TLR4 activation and antimicrobial resistance. J Biol Chem 285(21):15828–15836. https://doi.org/10.1074/jbc.M110.102061
Vašl J, Oblak A, Gioannini TL, Weiss JP, Jerala R (2009) Novel roles of lysines 122, 125, and 58 in functional differences between human and murine MD-2. J Immunol 183(8):5138–5145. https://doi.org/10.4049/jimmunol.0901544
Vaure C, Liu Y (2014) A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol 5:316. https://doi.org/10.3389/fimmu.2014.00316
Vikbladh I (1951) Studies on zinc in blood II. Scand J Clin Lab Invest 3(Suppl. 2):1–74
Vitovec J, Koudela B, Sterba J, Tomancova I, Matyas Z, Vladik P (1989) The gnotobiotic piglet as a model for the pathogenesis of Campylobacter jejuni infection. Zentralblatt fur Bakteriologie: Int J Med Microbiol 271(1):91–103. https://doi.org/10.1016/s0934-8840(89)80058-1
Vogel SN, Madonna GS, Wahl LM, Rick PD (1984) Stimulation of spleen cells and macrophages of C3H/HeJ mice by a lipid A precursor derived from Salmonella typhimurium. Clinical Infect Dis 6(4):535–541. https://doi.org/10.1093/clinids/6.4.535
Vollaard E, Clasener H (1994) Colonization resistance. Antimicrobial Agents Chemotherapy 38(3):409. https://doi.org/10.1128/aac.38.3.409
Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, Li X (2003) SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling. Nature Immunol 4(9):920–927. https://doi.org/10.1038/ni968
Walker CF, Black RE (2004) Zinc and the risk for infectious disease. Annu Rev Nutr 24:255–275. https://doi.org/10.1146/annurev.nutr.23.011702.073054
Walker WA (2017) The importance of appropriate initial bacterial colonization of the intestine in newborn, child, and adult health. Pediatr Res 82(3):387–395. https://doi.org/10.1038/pr.2017.111
Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, Liang X, Valentine C, Hellman J, Hayden D, Cavaillon JM (2010) Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis 201(2):223–232. https://doi.org/10.1086/649557
Watson RO, Novik V, Hofreuter D, Lara-Tejero M, Galan JE (2007) A MyD88-deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection. Infect Immun 75(4):1994–2003. https://doi.org/10.1128/iai.01216-06
Weindl G, Naglik JR, Kaesler S, Biedermann T, Hube B, Korting HC, Schaller M (2007) Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J. Clinical Investig 117(12):3664–3672. https://doi.org/10.1172/JCI28115
Xiao H, Gulen MF, Qin J, Yao J, Bulek K, Kish D, Altuntas CZ, Wald D, Ma C, Zhou H, Tuohy VK, Fairchild RL, de la Motte C, Cua D, Vallance BA, Li X (2007) The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26(4):461–475. https://doi.org/10.1016/j.immuni.2007.02.012
Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S (2003) TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4(11):1144–1150. https://doi.org/10.1038/ni986
Young CR, Ziprin RL, Hume ME, Stanker LH (1999) Dose response and organ invasion of day-of-hatch Leghorn chicks by different isolates of Campylobacter jejuni. Avian Dis 43(4):763–767
Young KT, Davis LM, Dirita VJ (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5(9):665–679. https://doi.org/10.1038/nrmicro1718
Yrios JW, Balish E (1985) Colonization and pathogenesis of Campylobacter spp. in athymic and euthymic germfree mice. Prog Clin Biol Res 181:199–202
Yrios JW, Balish E (1986a) Colonization and infection of athymic and euthymic germfree mice by Campylobacter jejuni and Campylobacter fetus subsp. fetus Infect Immun 53(2):378–383. https://doi.org/10.1128/IAI.53.2.378-383.1986
Yrios JW, Balish E (1986b) Immune response of athymic and euthymic germfree mice to Campylobacter spp. Infect Immun 54(2):339–346. https://doi.org/10.1128/IAI.54.2.339-346.1986
Yrios JW, Balish E (1986c) Pathogenesis of Campylobacter spp. In: athymic and euthymic germfree mice. Infect Immun 53(2):384–392. https://doi.org/10.1128/IAI.53.2.384-392.1986
Zhang Q, Sahin O (2020) Campylobacteriosis. Diseases of poultry 12th edn, pp 754–769
Acknowledgements
This work is supported by the German Federal Ministry of Education and Research (BMBF) in frame of the zoonoses research consortium PAC-Campylobacter to S.B. and M.M.H. (project IP7 01KI1725D).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mousavi, S., Bereswill, S., Heimesaat, M.M. (2021). Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections. In: Backert, S. (eds) Fighting Campylobacter Infections. Current Topics in Microbiology and Immunology, vol 431. Springer, Cham. https://doi.org/10.1007/978-3-030-65481-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-65481-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65480-1
Online ISBN: 978-3-030-65481-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)